Cure My Disease

Don't miss your cure!

 Log in / Sign up

New hemophilia drug enters human testing

NCT ID NCT05987449

Recruiting now Disease control Sponsor: Hoffmann-La Roche Source: ClinicalTrials.gov ↗

Summary

This early-stage study is testing a new drug called NXT007 in males with moderate to severe hemophilia A, including those with and without inhibitors. The main goals are to check if the drug is safe, how it moves through the body, and if it helps reduce bleeding episodes. The study will include adult, adolescent, and pediatric participants.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEMOPHILIA A are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Auckland Cancer Trial Centre

    RECRUITING

    Auckland, 1023, New Zealand

  • British Columbia Children's Hospital

    RECRUITING

    Vancouver, British Columbia, V6H 3N1, Canada

  • Georgetown Uni Medical Center

    WITHDRAWN

    Washington D.C., District of Columbia, 20007, United States

  • Hamilton Health Sciences Corporation

    RECRUITING

    Hamilton, Ontario, L8N 3Z5, Canada

  • Hospital Regional Universitario Carlos Haya

    ACTIVE_NOT_RECRUITING

    Málaga, 29010, Spain

  • Hospital Sant Joan de Deu

    RECRUITING

    Esplugues de Llobregat, Barcelona, 08950, Spain

  • Hospital Universitario la Paz

    RECRUITING

    Madrid, 28046, Spain

  • Indiana Hemophilia & Thrombosis center

    RECRUITING

    Indianapolis, Indiana, 46260, United States

  • Instytut Hematologii i Transfuzjologii

    RECRUITING

    Warsaw, 02-776, Poland

  • Istituto Clinico Humanitas

    RECRUITING

    Rozzano (MI), Lombardy, 20089, Italy

  • UC Davis Cancer Center

    RECRUITING

    Sacramento, California, 95817, United States

  • University of Iowa Hospitals and Clnics Dept of Pediatrics

    RECRUITING

    Iowa City, Iowa, 52242, United States

  • Uniwersyteckie Centrum Kliniczne

    RECRUITING

    Gda?sk, 80-214, Poland

Conditions

Explore the condition pages connected to this study.

HEMOPHILIA A